|
2025
|
Invention
|
Double stranded oligonucleotide compositions and methods relating thereto. The present disclosure... |
|
|
Invention
|
Oligonucleotide compositions and methods thereof. Among other things, the present disclosure prov... |
|
|
Invention
|
Technologies useful for oligonucleotide preparation. Among other things, the present disclosure p... |
|
2024
|
Invention
|
Phasing.
Among other things, the present disclosure pertains to methods and compositions related... |
|
|
Invention
|
Inhibin subunit beta e-related double stranded oligonucleotide compositions and methods relating ... |
|
|
G/S
|
Nucleic acid sequences and chemical reagents for medical purposes; pharmaceutical preparations fo... |
|
|
G/S
|
Nucleic acid sequences and chemical reagents for medical
purposes; pharmaceutical preparations f... |
|
|
Invention
|
Hsd17b13-related double stranded oligonucleotide compositions and methods relating thereto.
The ... |
|
|
Invention
|
Double stranded oligonucleotide compositions and methods relating thereto.
The present disclosur... |
|
|
Invention
|
Double stranded oligonucleotide compositions for rna interference and methods relating thereto. T... |
|
2023
|
Invention
|
Compositions and methods for phosphoramidite and oligonucleotide synthesis.
The present disclosu... |
|
|
Invention
|
Oligonucleotide compositions and methods thereof.
Among other things, the present disclosure pro... |
|
|
Invention
|
Compounds, compositions and methods for synthesis. The present disclosure, among other things, pr... |
|
|
Invention
|
Compositions for editing ass1 transcripts and methods thereof. Among other things, the present di... |
|
|
Invention
|
Chiral control.
The present invention relates to chirally controlled oligonucleotides, chirally ... |
|
|
Invention
|
Oligonucleotide compositions and methods thereof.
Among other things, the present disclosure rel... |
|
|
Invention
|
Oligonucleotide compositions and methods relating thereto.
The present disclosure features usefu... |
|
|
Invention
|
Oligonucleotide compositions and methods relating thereto. The present disclosure features useful... |
|
|
Invention
|
Technologies for oligonucleotide preparation.
Among other things, the present disclosure provide... |
|
|
Invention
|
Oligonucleotide compositions and methods thereof for exon skipping.
Among other things, the pres... |
|
|
Invention
|
Oligonucleotide compositions and methods thereof for exon skipping. Among other things, the prese... |
|
|
Invention
|
Immunoassays for detecting wild type huntingtin protein and methods of treatment employing such i... |
|
|
Invention
|
Stereoselective technologies for chiral compounds.
Among other things, the present disclosure pr... |
|
|
Invention
|
Stereoselective technologies for chiral compounds. Among other things, the present disclosure pro... |
|
2022
|
Invention
|
Methods and compositions of biologically active agents.
In some embodiments, the present disclos... |
|
|
Invention
|
Hsd17b13-related double stranded oligonucleotide compositions and methods relating thereto. The p... |
|
|
Invention
|
Compositions for editing mecp2 transcripts and methods thereof.
Among other things, the present ... |
|
2021
|
Invention
|
Cells and non-human animals engineered to express adar1 and uses thereof.
Among other things, th... |
|
|
Invention
|
Oligonucleotide compositions and methods thereof.
The present disclosure provides modified oligo... |
|
2020
|
Invention
|
Oligonucleotide compositions and methods of use thereof.
Among other things, the present disclos... |
|
2019
|
G/S
|
Oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of genet... |
|
|
G/S
|
Research and development of oligonucleotide drug delivery platforms for use in the treatment of g... |
